Waneta Tuttle


Dr. Tuttle is owner and chief executive officer of SMV. Over the past 15 years, she has served as start-up chief executive officer for new companies founded with innovative technologies and approaches for solving problems in health care. She was founding chief executive officer of Indigo Medical (now owned by Johnson & Johnson's Ethicon Endosurgery), Patient Technologies, Inc., and PhDx Systems, Inc. She is currently chief executive officer and co-founder of Exagen Diagnostics, Inc.

Dr. Tuttle serves on the Board of Directors of MGI Pharma, Inc. (NASDAQ: MOGN) and Health Care Service Corporation, a mutual legal reserve company operating Blue Cross/Blue Shield of Illinois, Texas, Oklahoma and New Mexico. She continues to be a Director of Exagen Diagnostics, Inc. and PhDx Systems, Inc. and is a Member of the Corporation at the Charles Stark Draper Laboratories in Boston.

Prior to starting SMV in 1992, Dr. Tuttle held positions of increasing responsibility over 23 years at the Lovelace Medical Foundation in Albuquerque. She began her career at the Foundation as a research scientist, and then served for many years as its vice president and chief operating officer. She was also a member of the management committee for the integrated health care delivery system at Lovelace and served on the Boards of Directors for several of the Lovelace organizations.

Dr. Tuttle holds a PhD in biology with a concentration in physiology. She also holds an MBA from the R.O. Anderson Schools of Management at the University of New Mexico where she serves on its National Advisory Board.